Phase 1 study of PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor, for the treatment of acute myeloid leukemia and myelodysplastic syndrome

G. J. Roboz, F. J. Giles, A. F. List, J. E. Cortes, R. Carlin, M. Kowalski, S. Bilic, E. Masson, M. Rosamilia, M. W. Schuster, D. Laurent, E. J. Feldman

Research output: Contribution to journalArticlepeer-review

75 Scopus citations

Fingerprint Dive into the research topics of 'Phase 1 study of PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor, for the treatment of acute myeloid leukemia and myelodysplastic syndrome'. Together they form a unique fingerprint.

Medicine & Life Sciences